Jinwon Jung
Senior Director ABL Bio
Seminars
Tuesday 4th November 2025
Studying & Developing Bispecific ADCs From Early Discovery to IND-Enabling Studies
12:00 pm
- Exploring bispecific ADCs as an emerging and promising next-generation ADC modality
- Outlining the rationale behind target combinations for bispecific ADC design
- Assessing the preclinical safety and efficacy of bispecific ADCs in comparison to monospecific ADCs for clinical trials
